We can't find the internet
Attempting to reconnect
25771.1 PFLS-LS
Immobilized sortase enzymes for the Production of Antibody-drug conjugates IMPACT
Zusammenfassung
Immobilized sortase enzymes for the Production of Antibody-drug conjugates IMPACT
Weitere Texte
Abstract
The application of enzymes in continuous production processes is often hindered by the fragility of these natural biocatalysts under operational conditions. In IMPACT, the project partners shall strive to develop a novel nanobiocatalytic material allowing for a drastically enhanced stability of enzymes. The protection strategy relies on the growth, at the surface of immobilized enzymes, of a protective biomimetic layer partially shielding the enzyme. While this layer will provide the enzyme with enhanced resistance to operational stress conditions, its partial nature (i.e. covering only partially the enzyme) will allow the use of this nanomaterial for applications where large substrates are targeted. This is the case in IMPACT as the targeted application is the production of antibody-drug conjugates for use in cancer therapy (multiple myeloma). The project partners shall focus on the development of the nanobiocatalytic material and demonstrate the superiority of the nanobiocatalysts produced as compared to the soluble or immobilized counterparts. In a further phase, the technology developed in IMPACT will be implemented in a flow-through reactor enabling the continuous production of ADCs. Besides the targeted application, IMPACT is expected to open a wealth of new opportunities for the implementation partners for empowering enzymes in different industrial applications.
Beteiligte
Yves Dudal
Wirtschaftspartner
yves.dudal@inofea.com
INOFEA AG Yves Dudal Hochbergerstr. 60c 4057 Basel BS CH
Patrick Shahgaldian
Kontaktperson
patrick.shahgaldian@fhnw.ch
FHNW Fachhochschule Nordwestschweiz Patrick Shahgaldian Hofackerstrasse 30 4132 Muttenz BL CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2017-04-30
- Enddatum
- 2019-01-31
- Bewilligte Gesamtkosten
- CHF 250110.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%